Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CHENOPODIUM ALBUM POLLEN: 91 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
91
Total FAERS Reports
0
Deaths Reported
4
Hospitalizations
91
As Primary/Secondary Suspect
3
Life-Threatening
ALK-Abello, Inc.
Manufacturer

Drug Class: Allergens [CS] · Manufacturer: ALK-Abello, Inc. ·

First Report: 20150318 · Latest Report: 20250304

What Are the Most Common CHENOPODIUM ALBUM POLLEN Side Effects?

#1 Most Reported
Anaphylactic reaction
27 reports (29.7%)
#2 Most Reported
Urticaria
18 reports (19.8%)
#3 Most Reported
Dyspnoea
16 reports (17.6%)

All CHENOPODIUM ALBUM POLLEN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Anaphylactic reaction 27 29.7% 0 2
Urticaria 18 19.8% 0 0
Dyspnoea 16 17.6% 0 2
Injection site reaction 9 9.9% 0 0
Throat tightness 9 9.9% 0 0
Local reaction 8 8.8% 0 1
Pruritus 8 8.8% 0 0
Throat irritation 8 8.8% 0 0
Wheezing 8 8.8% 0 0
Chest discomfort 6 6.6% 0 0
Eye pruritus 6 6.6% 0 0
Flushing 6 6.6% 0 0
Injection site urticaria 6 6.6% 0 1
False negative investigation result 5 5.5% 0 1
Hypersensitivity 5 5.5% 0 0
Injection site erythema 5 5.5% 0 1
Sneezing 5 5.5% 0 0

Who Reports CHENOPODIUM ALBUM POLLEN Side Effects? Age & Gender Data

Gender: 56.6% female, 43.4% male. Average age: 37.3 years. Most reports from: US. View detailed demographics →

Is CHENOPODIUM ALBUM POLLEN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2015 6 0 0
2016 12 0 0
2017 7 0 0
2018 8 0 0
2019 3 0 0
2020 7 0 1
2021 17 0 0
2022 9 0 2
2023 2 0 0
2024 6 0 0
2025 3 0 0

View full timeline →

What Is CHENOPODIUM ALBUM POLLEN Used For?

IndicationReports
Product used for unknown indication 12
Skin test 9

Other Drugs in Same Class: Allergens [CS]

Official FDA Label for CHENOPODIUM ALBUM POLLEN

Official prescribing information from the FDA-approved drug label.